Quote:
Originally Posted by Fuzz
|
I read the entire study linked from this story. It is a really very interesting read.
http://pharmacare2020.ca/assets/pdf/..._in_Canada.pdf
I'm with it nearly to the end - and then I have some reservations. It starts somewhere around here:
Quote:
Comparable health care systems around the world
achieve lower prices by using the purchasing power of
a single payer for pharmaceuticals. Manufacturers who
price competitively get the reward of their drugs being
covered for 100% of the population. The savings can be
remarkable.
|
I am not sure a monopoly should be given to any one manufacturer/developer based on best price versus best efficacy/safety/patient outcomes.
Biologic drugs would be my best example. They are very expensive but can provide incredible benefits and provide quality of life and return dignity to people who otherwise would have no opportunity to enjoy meaningful, productive lives. In most disease areas where these drugs are applicable, there are a few choices and little consensus as to which is 'the best' in terms of safety/efficacy. I am not sure one product should get a monopoly for 100% of the population, simply on the basis of cost.
Depending on the mechanism of this part of the plan, I think it would be entirely fantastic for all Canadians.